Last update 23 Aug 2025

APG-2305

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
APG 101.10, APG2305
Target
IL-23R x TNFR2 x VEGFR2
Action
inhibitors, antagonists
Mechanism
IL-23R inhibitors(Interleukin 23 Receptor inhibitors), TNFR2 antagonists(Tumor necrosis factor receptor superfamily member 1B antagonists), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Arthritis, Psoriatic
Originator Organization
Allostera Pharma, Inc.Allostera Pharma, Inc.
Active Organization-
Inactive Organization
Allostera Pharma, Inc.Allostera Pharma, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with APG-2305
Login to view more data
100 Translational Medicine associated with APG-2305
Login to view more data
100 Patents (Medical) associated with APG-2305
Login to view more data
1
Literatures (Medical) associated with APG-2305
01 Mar 2010IDrugs : the investigational drugs journal
BioPartnering North America--Spotlight on Canada.
100 Deals associated with APG-2305
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, PsoriaticPreclinical-
Allostera Pharma, Inc.Allostera Pharma, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free